Twitter Logo Youtube Circle Icon LinkedIn Icon

United States > Antitrust > Merger control > Law firm and leading lawyer rankings


Index of tables

  1. Merger control
  2. Hall of Fame
  3. Leading lawyers
  4. Next generation lawyers

Hall of Fame

  1. 1

Leading lawyers

  1. 1

Next generation lawyers

  1. 1

Who Represents Who

Find out which law firms are representing which Merger control clients in United States using The Legal 500's new comprehensive database of law firm/client relationships. Instantly search over 925,000 relationships, including over 83,000 Fortune 500, 46,000 FTSE350 and 13,000 DAX 30 relationships globally. Access is free for in-house lawyers, and by subscription for law firms. For more information, contact


Trusted Advisor - with Finnegan

IP specialist Finnegan detail how their collaborative approach makes for a unique culture which is designed to allow them to work with clients in a way which is cognizant of the challenges facing all companies today.

Cleary Gottlieb Steen & Hamilton LLP is among the market leaders for big-ticket US and global merger clearances. Nearly half of the senior-level practitioners in its antitrust team have significant experience practicing in Brussels, adding real credibility to its advice on European antitrust issues. The firm also excels in Chinese merger reviews. In 2017, George Cary, Elaine Ewing and counsel Cunzhen Huang assisted Dow Chemical with obtaining clearances in more than 20 jurisdictions for its $130bn merger of equals with DuPont. David Gelfand, global practice co-chair Mark Leddy (who divides his practice between Washington DC and New York) and Daniel Culley (who splits his time between Washington DC and Brussels) are acting as global antitrust counsel to Essilor in its $49bn acquisition of Luxottica. Also recommended are Mark Nelson, Brian Byrne, Leah Brannon, Kenneth Reinker and Jeremy Calsyn. Named individuals are based in Washington DC, except where otherwise stated.

Dechert LLP’s heavyweight team includes Paul Friedman, Michael Weiner and Ethan Litwin, who acted as lead trial counsel to Monsanto and its Precision Planting equipment business in the DOJ’s lawsuit challenging Deere & Co’s $190m acquisition of Precision Planting. In another highlight, Weiner and counsel Jill Ross are working with the Brussels and Hong Kong offices to assist SK Hynix (a subsidiary of SK Telecom) with obtaining clearances across multiple jurisdictions for its $18bn consortium bid with Bain Capital and others to acquire Toshiba’s NAND business. Paul Denis and Craig Falls are other key figures in the group, which has also acted for third parties in transactions, such as US Ecology and Amicus Economists. Weiner leads the team with Philadelphia-based Steven Bizar. Named individuals are located in New York or Washington DC, except where otherwise stated.

Jones Day, which is a major force in multibillion-dollar transactions, handles the entire ambit of antitrust issues for US and global companies. In 2017, a team led by Phillip Proger, John Majoras and San Francisco-based Margaret Ward acted as antitrust and trial counsel to Aetna in its $37bn acquisition of fellow health insurer Humana. Another matter saw Majoras, Julia McEvoy and others advise Parker Hannifin on a lawsuit filed by the DOJ challenging the client’s $4.3bn acquisition of Clarcor Inc; this matter represented the first DOJ challenge of a consummated merger under the Trump administration. Other practitioners are Michael Knight, recently promoted partner Aimee DeFilippo, Kenneth Field, Michael Gleason and Chicago-based Erin Shencopp. Named individuals are located in Washington DC, except where otherwise stated. David Wales departed the firm.

Skadden, Arps, Slate, Meagher & Flom LLP's US team works with the wider global network on complex cross-border antitrust issues associated with megadeals. Having successfully negotiated US merger clearance in 2017, an international team including Steven Sunshine, Steven Albertson and New York-based Maria Raptis is advising NXP Semiconductors on merger reviews involving other jurisdictions around the world in relation to its $47bn takeover by Qualcomm. Sunshine and Raptis, along with members of the Brussels and Beijing offices, assisted HP with obtaining unconditional EU approval of its $1.05bn acquisition of Samsung’s printer business, following a phase one review by the European Commission (EC). Tara Reinhart is another key figure, as is Clifford Aronson in New York. Named individuals are based in Washington DC, except where otherwise stated.

Weil, Gotshal & Manges LLP fields numerous heavyweight practitioners with experience in high-ranking government positions; Jeffrey Perry formerly headed up the FTC’s Mergers IV Division. In addition, Steven Newborn, Ann Malester and Steven Bernstein each have the experience of having led the FTC’s Mergers I Division. New York-based Kevin Arquit’s experience includes acting as director of the FTC’s Bureau of Competition. In 2017, a team including Newborn, Bernstein, Perry, Jeff White and counsel Vadim Brusser assisted Walgreens Boots Alliance with obtaining FTC clearance of its acquisition of around 2,000 Rite Aid stores. Another highlight involved Malester, John Scribner and others acting as antitrust counsel to Abbott Laboratories in its $5.3bn acquisition of Alere Inc. Brianne Kucerik is recommended. Named individuals are based in Washington DC unless otherwise stated.

In 2017, Debbie Feinstein re-joined Arnold & Porter as global antitrust practice head, having served as director of the FTC’s Bureau of Competition. In addition, Bill Baer returned to the firm from the DOJ, where he held the position of acting associate attorney general - among others. Jonathan Gleklen assisted Monsanto with antitrust issues relating to its $66bn takeover by Bayer, and is also advising the same client on the proposed sale of its Precision Planting equipment business to AGCO. Another key client is General Electric (GE); recent highlights include handling the antitrust aspects of the combination of GE Oil & Gas and Baker Hughes, and of GE’s $1.65bn acquisition of LM Wind Power. BP, Anthem and Cristal USA are among other clients. Other key figures are Richard Rosen, Michael B. Bernstein and Claudia Higgins. Scott Lent practices in New York. Named partners are based in Washington DC, except where otherwise stated.

New York-based Cravath, Swaine & Moore LLP’s practice is led by Christine Varney, who acted as antitrust counsel to Alere Inc in its $8bn sale to Abbott Laboratories in 2017. Julie North advised Crown Castle International Corp on antitrust issues associated with its $7.1bn acquisition of LTS Group Holdings from Berkshire Partners, Pamlico Capital and other investors. Yonatan Even is another first-rate practitioner in the team.

In 2017, Davis Polk & Wardwell LLP’s Ronan Harty (New York), Jon Leibowitz (who divides his time between Washington DC and New York) and Washington DC-based Jesse Solomon acted as antitrust counsel to Syngenta in its proposed $43bn takeover by ChemChina. Arthur Burke, who splits his time between the New York and Menlo Park offices, advised Suez on the antitrust aspects of its $3.4bn acquisition of GE Water & Process Technologies from General Electric. Reckitt Benckiser, Equinix and Comcast are other notable clients.

Kirkland & Ellis LLP has a strong track record negotiating clearances of complex multibillion-dollar transactions with significant competition issues. Ian John, Peter McCormack, Chicago-based James Mutchnik and others advised Bain Capital on its $3.2bn carve-out acquisition of Sealed Air’s Diversey Care division, and also its food hygiene and cleaning business. The team also assisted the same client with the $1.2bn sale of Consolidated Container Company to Loews Corporation. Illustrative of its other work, John and Katherine Rocco acted as antitrust counsel to AkzoNobel in its successful defense against an unsolicited takeover attempt by PPG in 2017. Matthew Reilly, Mark Kovner, Marin Boney and recent hire Carla Hine (who joined from McDermott Will & Emery LLP in 2017) are among the practitioners based in Washington DC. Named individuals are based in New York, except where otherwise stated.

Latham & Watkins LLP features prominently in headline deals that are subject to particularly intensive regulatory scrutiny. Its extensive industry coverage spans areas such as pharmaceuticals, media and entertainment, technology and telecoms, among others. Global co-chair Amanda Reeves, Michael Egge, counsel Farrell Malone and others are acting as global antitrust counsel to Agrium Inc in its $36bn merger of equals with Potash Corporation of Saskatchewan. In 2017, Reeves, Marcellus Williamson and counsel Alan Devlin were part of a cross-border team that assisted Integra LifeSciences with obtaining global clearances for its $1bn acquisition of Codman Neurosurgery from Johnson & Johnson. Joshua Holian, Karen Silverman and Daniel Wall are names to note in San Francisco. Named individuals are based in Washington DC, except where otherwise stated.

Simpson Thacher & Bartlett LLP is an antitrust powerhouse in sophisticated US deals and cross-border transactions involving multiple regulators. Recent work includes New York-based Peter Guryan, Peter Thomas and counsel Ellen Frye (also in New York) working with the London office to assist ChemChina with the antitrust review of its $43bn acquisition of Syngenta; the team successfully negotiated clearances by the FTC, Committee on Foreign Investment in the United States (CFIUS) and EC. Thomas also worked alongside Andrew Lacy, counsel Peter Herrick and others to advise Siliconware Precision Industries on the FTC’s investigation into its merger with Advanced Semiconductor Engineering. Sara Razi is another name to note, as is recently promoted New York-based counsel Richard Jamgochian. Named individuals are located in Washington DC, except where otherwise stated.

Sullivan & Cromwell LLP’s Steven Holley in New York and Washington DC-based Joseph Matelis are working with the London office to assist Praxair with managing antitrust concerns in more than 20 jurisdictions regarding the client’s pending $67bn merger of equals with Linde AG. Holley is also leading a cross-office team to advise Bayer on the merger clearance issues associated with its pending $66bn mega-merger with Monsanto in the agrichemical industry. In addition to Holley, Yvonne Quinn, Eric Queen and Bradley Smith are other names to note in New York. Renata Hesse, who formerly headed the DOJ’s Antitrust Division as acting assistant attorney general, joined the Washington DC office in 2017. Also based in Washington DC is office managing partner Daryl Libow. Adam Paris is based in Los Angeles.

Baker Botts L.L.P.’s antitrust practice chair Stephen Weissmanknows the ins and outs of the antitrust regulators in the US’. Weissman’s team, which also includes such names as John Taladay, Sean Boland and Joseph Ostoyich, also assists clients with merger reviews involving the EC and other international agencies. Paul Cuomo is acting for RealPage in the DOJ’s second request review of its proposed $300m acquisition of Lease Rent Options and other assets from The Rainmaker Group, and is also handling the antitrust aspects of the client’s $250m acquisition of OnSite Manager’s assets. In addition, Boland, Weissman and Michael Perry are acting as antitrust counsel to Valero in its proposed acquisition of petroleum storage facilities and distribution terminals in California. All named individuals are based in Washington DC.

Crowell & Moring LLP’s antitrust team is at the front end of many headline multibillion-dollar mergers and acquisitions. Shawn Johnson and Joseph Miller were key advisers to Humana (as part of the firm’s role as the lead counsel to the client) regarding the DOJ investigation and challenge of its $37bn merger with Aetna. Wm. Randolph Smith, Johnson, New York-based attorney Olivier Antoine and others are acting as antitrust counsel to AT&T in its merger with Time Warner; the DOJ has filed a lawsuit to block the transaction. In addition, Megan Wolf, Antoine and Mary Anne Mason assisted TransCanada with obtaining FTC clearance for its $13bn acquisition of Columbia Pipeline Group. The practice has gone from strength to strength, with New York-based practitioner Juan Arteaga (the former deputy assistant attorney general for civil enforcement at the DOJ’s Antitrust Division) and Alexis Gilman (most recently serving as the assistant director at the Mergers IV Division of the FTC’s Bureau of Competition) joining the team. Shari Lahlou and Los Angeles-based Jason Murray chair the antitrust practice. Named individuals are based in Washington DC, except where otherwise stated.

Freshfields Bruckhaus Deringer LLP’s global footprint enables it to handle all types of antitrust-related complexities associated with high-profile transactions for US and international clients. Illustrative of the team’s breadth of experience, Richard Snyder has expertise in Latin American merger filings, while Hiram Andrews (New York) and Justin Stewart-Teitelbaum are particularly knowledgeable of European merger control matters. The team, which is led by Paul Yde, also represents clients before the FTC, DOJ and US state attorneys general. In 2017, Yde and Mary Lehner were part of a cross-border team that assisted Johnson & Johnson with obtaining global merger clearance for its $30bn acquisition of Swiss biotech company Actelion Pharmaceuticals. Bruce McCulloch, senior associate Jennifer Mellott and others acted as global antitrust counsel to Maersk Line in its $3.7bn acquisition of Hamburg Süd from the Dr Oetker Group. Other practitioners with significant merger control experience include Thomas Ensign, senior associates Jan Rybnicek and Laura Collins, and of counsel Terry Calvani. Special counsels Shawn Cooley and Christine Laciak have expertise in CFIUS-related reviews. Named individuals are based in Washington DC, except where otherwise stated.

Gibson, Dunn & Crutcher LLP has a strong track record in US and cross-border filings, and also in FTC and DOJ merger challenges. In a particularly headline-grabbing matter, the firm is acting for AT&T in the DOJ’s lawsuit challenging the client’s proposed $85bn acquisition of Time Warner; the lead partners are Robert Walters (who divides time between Dallas and Houston), Sean Royall (Dallas/Washington DC) Eric Stock (New York) and Adam Di Vincenzo (Washington DC). Elsewhere, the team has been particularly active in merger control matters in the healthcare sector; in 2017, this included advising Seattle-based Group Health Cooperative on its $1.8bn sale to Kaiser Permanente. Denver-based Richard Cunningham made partner in January 2018, and Joel Sanders has retired. Royall, Daniel Swanson (Los Angeles) and Scott Hammond (Washington DC) jointly head the antitrust practice. Cynthia Richman in Washington DC is also noted. Joshua Soven joined Wilson Sonsini Goodrich & Rosati, while Richard Parker joined in Washington DC from O'Melveny & Myers LLP

Hogan Lovells US LLP’s US team undertakes matters on a standalone basis, and also works with non-US offices across the global network in complex multi-jurisdictional billion-dollar transactions. The group fields a number of seasoned practitioners in the merger control space, including Joseph Krauss, Janet McDavid and Robert Leibenluft (who focuses on the healthcare and life sciences sector). Leigh Oliver and senior associates Lauren Battaglia and Robert Baldwin are working with members of the London office to advise LabCorp on the antitrust aspects of its $1.2bn acquisition of UK-based Chiltern. In 2017, Oliver and others successfully defended Advocate Health Care Network against the FTC’s action to stop the client’s merger with NorthShore University HealthSystem. Logan Breed, Rachel Brandenburger in New York and Meghan Rissmiller are other recommended individuals. Edith Ramirez, who joined the firm in September 2017, succeeded McDavid as head of the US team. Named individuals are based in Washington DC, except where otherwise stated. Since publication, Robert Robertson has moved to DLA Piper LLP (US).

Mayer Brown has a full-service practice covering all aspects of merger control, including pre-merger analysis (such as advice on strategic structurings and transactions to balance competition concerns), Hart-Scott-Rodino (HSR) and international filings, and merger investigations and litigation. William Stallings and Mark Ryan acted for CNH Industrial as the initial complainant in the DOJ’s lawsuit seeking to block Deere & Company’s proposed acquisition of Precision Planting from Monsanto. The team also advised CNH on a review of the same transaction by Brazilian antitrust agency CADE. In 2016, Stallings, Ryan and counsel Meytal McCoy advised Virgin America on the DOJ’s review of its proposed takeover by Alaska Air Group, and also on a related private lawsuit. More recently, Scott Perlman and senior counsel Adrian Steel are acting for Global Houghton in the FTC’s second request investigation into the proposed $1.4bn sale of the business to Quaker Chemical; the firm’s Brussels office is handling a related investigation in Europe. All named individuals are based in Washington DC.

McDermott Will & Emery LLP is particularly strong in obtaining clearances in hospital and other healthcare sector mergers. Raymond Jacobsen leads the team, which also has expertise in defense and consumer goods, among other areas. In 2017, Joel Grosberg, Gregory Heltzer and Daniel Powers assisted DaVita with successfully negotiating FTC clearance for its $360m acquisition of Renal Ventures Management. Jeffrey Brennan and Powers recently obtained clearances from the states of Tennessee and Virginia on behalf of Mountain States Health Alliance in relation to its merger with not-for-profit healthcare provider Wellmont Health System. Other key figures in the group are Stephen Wu in Chicago, William Díaz in Orange County and Jon Dubrow. Named individuals are based in Washington DC, except where otherwise stated.

Morgan, Lewis & Bockius LLP handles a high volume of HSR and non-US filings, and also provides assistance with merger investigations. In addition, another cornerstone of the practice is the team’s advocacy work in merger-related litigation. In 2017, Harry Robins in New York and Washington DC-based Scott Stempel and David Brenneman acted as antitrust counsel to animal health company Zoetis in its acquisition of Nexvet Biopharma. Brenneman made partner in October 2017. Intercontinental Exchange and Apollo Global Management are among the firm’s other clients. Steven Reed in Philadelphia is the global practice head.

O'Melveny & Myers LLP is especially sought after by clients due to its strengths in extensive regulatory investigations and merger-related litigation. In 2017, Ted Hassi assisted Bass Pro Group with obtaining clearance for its $4.2bn merger with Cabela’s Incorporated, following an intensive second request investigation by the FTC. In another highlight, Ben Bradshaw, Los Angeles-based partner Kenneth O’Rourke and Courtney Dyer successfully obtained DOJ clearance on behalf of Alaska Airlines for its proposed $4bn acquisition of Virgin America; the DOJ’s clearance of the deal followed a now-settled lawsuit brought by several private plaintiffs seeking to block the transaction. Ian Simmons. Katrina Robson is also noted. Named individuals are based in Washington DC, except where otherwise stated.

Paul Hastings LLP’s highly rated US team is supported by a wider network of international offices, giving it an enhanced capability in transactions requiring multi-jurisdictional clearances, and involving other cross-border antitrust issues. In 2017, demonstrating its work on major matters, Scott Hataway and senior associate Michael Wise advised Samsung on antitrust issues associated with its $8bn acquisition of Harman International Industries (the largest Korean outbound M&A transaction on record). In addition, MJ Moltenbrey and Wise are assisting Monsanto with antitrust issues associated with its $66bn sale to Bayer. Dick Clark Productions, CDH Investment Partners and Electrolux are among other recent clients. All named individuals are based in Washington DC.

Paul, Weiss, Rifkind, Wharton & Garrison LLP’s team is ‘at the high end of the scale for knowledge, expertise and experience’ when it comes to high-stakes merger control matters. Key figures include Jonathan Kanter, who is ‘available around the clock’, and New York-based Aidan Synnott, who delivers ‘level-headed, thoughtful and practical advice’. Synnott heads the practice with Kenneth Gallo, Charles Rule and Joseph Simons. In 2017, a team including Scott Barshay in New York and Andrew Forman acted as corporate and antitrust counsel to Ariad Pharmaceuticals in its $5.2bn sale to Takeda Pharmaceutical. On the merger litigation front, Joseph Bial, counsel Daniel Howley and others represented Cigna in a lawsuit brought by the DOJ and several states seeking to block the client’s proposed $54bn headline merger with Anthem. The team has also acted for clients such as Kate Spade & Company, Virtu Financial and Eli Lilly. Named individuals are based in Washington DC, except where otherwise stated.

New York-based M&A powerhouse Wachtell, Lipton, Rosen & Katz assists clients with the antitrust issues connected to big-ticket transactions. In 2017, Damian Didden acted as antitrust counsel to Broadcom in its proposed acquisition of Qualcomm. Ilene Gotts’ recent work includes assisting Danone with obtaining DOJ clearance of its acquisition of WhiteWave. Nelson Fitts handles antitrust issues within sectors such as energy, pharmaceuticals and financial services, among others. Joseph Larson is another notable partner.

White & Case LLP delivers results in accordance with the expectations of global clients in US second request investigations, multi-jurisdictional merger reviews and merger litigation. The US merger control practice is anchored by George Paul and Rebecca Farrington, who worked alongside Mark Gidley, Christopher Curran and others to advise Anthem on the DOJ’s and plaintiff states’ lawsuit challenging the client’s proposed $54.2bn acquisition of Cigna. Farrington, Robert Milne in New York and counsel Anna Kertesz assisted Vertex Pharmaceuticals with obtaining FTC clearance (without remedies, following the issue of a second request) for its circa $250m acquisition of cystic fibrosis drug CTP-656 from Concert Pharmaceuticals. The firm has also acted for clients such as Calpine Corporation, Aramco Services Company and Sempra Energy. John Donaldson and counsel Douglas Jasinski are recommended. Named individuals are based in Washington DC, except where otherwise stated.

Akin Gump Strauss Hauer & Feld LLP has a strong client following in industries such as technology, financial services, energy and healthcare. It handles all stages of the merger process, ranging from cross-border merger analysis and merger filings to US/EC/UK CMA merger investigations and litigation. In 2017, Corey Roush, Paul Hewitt and others assisted VCA with successfully negotiating an FTC second request investigation and obtaining clearance for its $9.1bn sale to Mars Petcare. Roush was also the lead partner in a team which acted as antitrust counsel to 7-Eleven in its $3.3bn acquisition of Sunoco LP. Gorav Jindal has 18 years of transactional antitrust experience at public sector level and private practice. All named individuals are based in Washington DC.

In 2017, in a demonstration of Baker McKenzie LLP’s strengths in high-profile multi-jurisdictional deals, David Clanton and John Fedele advised Safran SA on the global merger review related to the divestment of Morpho Detection to Smiths. Other key figures in the team include Brian Burke and Teisha Johnson, who together acted as antitrust counsel to Konica Minolta in its $1bn acquisition of Ambry Genetics. The practice is gaining momentum under the leadership of North America antitrust head Mark Hamer, and was strengthened by the arrival of Creighton Macy at the firm in 2017. Macy joined from the DOJ, where he served as chief of staff and senior counsel in the Antitrust Division. Craig Lee is another active practitioner. All named individuals are based in Washington DC.

Cooley LLP’s team, which is led by Jacqueline Grise, assists clients with the antitrust aspects of US and international M&A, which includes handling related merger investigations. The group, which also includes Howard Morse and Marc Schildkraut, is particularly well known for acting for clients from hi-tech industries. Grise is acting for BroadSoft in its $1.9bn acquisition by Cisco. Another highlight involved assisting Dynamic Network Service with obtaining DOJ clearance for its sale to Oracle Corporation. All named individuals are based in Washington DC.

Debevoise & Plimpton LLP’s group, which is jointly led by Daniel Abuhoff and Gary Kubek, assists clients with negotiating merger clearances from the DOJ and FTC. It also works with practitioners located in offices outside of the US on multi-jurisdictional merger filings and cross-border investigations. Abuhoff, Kubek, Michael Schaper, Erica Weisgerber and Kyra Bromley are acting for Discovery Communications in the DOJ’s second request investigation into the client’s proposed $14.6bn acquisition of Scripps Networks Interactive. In 2017, the team advised Showa Denko KK on obtaining DOJ clearance for its acquisition of SGL Carbon’s worldwide graphite electrodes business. Kelso & Co, Pernod Ricard and Dover Corporation are other notable clients. All named individuals are based in New York.

At Fried, Frank, Harris, Shriver & Jacobson LLP, New York-based partner Nathaniel Asker is the main contact in the US, following former global chair Bernard Nigro’s appointment as deputy assistant attorney general at the DOJ. Tobias Caspary, who divides time between London and Frankfurt, is the key EU partner. Asker works closely with Caspary on all antitrust aspects of US and cross-border transactions. In 2017, highlights included acting as antitrust counsel to Coach in its $2.4bn acquisition of Kate Spade & Company, and advising Knight Transportation on its merger with Swift Transportation. Associate Aleksandr Livshits in New York is highly regarded.

Goodwin’s merger control head Andrea Murino (Washington DC) has ‘brought the practice to the next level and put the firm on the map’. A hallmark of the team is its ‘strong agency experience’, which was evident in 2017 when Murino, Andrew Goodman (New York) and Kirby Lewis (Boston) assisted Concert Pharmaceuticals with the FTC’s second request investigation of the client’s agreement to sell cystic fibrosis drug CTP-656 to Vertex Pharmaceuticals. Todd Hahn (New York) is another recommended individual in the team, whose clients include SGL Carbon, Eventbrite and TA Associates.

Linklaters LLP’s antitrust team provides ‘perfect guidance in a highly complex, international merger transaction’. Jeff Schmidt in Washington DC, who heads the department with New York partners Thomas McGrath and Douglas Tween, has ‘deep industry and government knowledge, and is measured and practical in his advice’. McGrath is leading a team - which includes counsel Antonia Sherman and senior associate John Eichlin in New York and members of the Beijing and Brussels offices - that is advising Linde on the global antitrust aspects of its $73bn merger of equals with Praxair. Another highlight saw McGrath, Sherman and practitioners in London and Beijing act as antitrust counsel to Siemens in a DOJ investigation into a merger of Siemens’ and Gamesa’s wind turbines businesses.

Morrison & Foerster LLP has ‘good people to work with’, who are ‘bright and engaged’ in transactional antitrust matters. In 2017, Jonathan Gowdy, Roxann Henry, David Meyer and others acted for Deere & Company in the high-profile DOJ lawsuit related to its proposed acquisition of Precision Planting’s equipment business. Another highlight involved Henry and Steven Kaufmann assisting Axalta Coating Systems with obtaining clearances from the FTC and Canadian Competition Bureau for its $420m acquisition of Valspar’s North American wood coatings business; this deal was a condition of Sherwin-Williams’ acquisition of Valspar. Jeff Jaeckel leads the US team. Stephen Smith has retired from private practice. All named individuals are based in Washington DC.

Norton Rose Fulbright US LLP handles all stages of the US and global merger review process for clients such as GCC America, Baylor Scott & White Healthcare, and Dentsply Sirona. In 2017, Daniel Wellington obtained unconditional FTC clearance on behalf of Good Shepherd Health System in relation to its acquisition by CHRISTUS Health. Wellington also assisted Gemalto with the antitrust aspects of its $850m acquisition of 3M’s identity management business. David Foster is another key figure. Layne Kruse, whose time is split between Houston and Washington DC, heads up the US antitrust practice. Wellington and Foster are based full time in Washington DC. Neely Agin joined Winston & Strawn LLP.

Orrick, Herrington & Sutcliffe LLP is viewed by many clients as a destination firm for merger control work. In the technology sector, names such as Microsoft, Apigee and Cisco have hired the firm specifically to handle the antitrust aspects of complex M&A transactions. Key figures in the team include James Tierney and Alex Okuliar, who together led the advice to Planet Labs on the antitrust aspects of its acquisition of Google’s Terra Bella satellite business. The firm also attracts work from sectors outside of technology, including healthcare, food products and industrial machinery. Okuliar and of counsel Patricia Zeigler advised Japanese pharmaceutical company Otsuka Pharmaceutical on antitrust issues associated with its acquisition of Neurovance. Jay Jurata leads the group, which also includes Garret Rasmussen. All named individuals are based in Washington DC.

Boston-based counsel Deidre Johnson leads Ropes & Gray LLP’s merger control practice. In addition, Ruchit Patel, who is a key contact in the London office, adds UK and EU competition law expertise to the global offering. The team handles HSR filings and co-ordinates multi-jurisdictional merger clearances, and also assists clients with merger investigations and challenges. In a multifaceted transaction, which required multiple HSR filings, the team acted as antitrust counsel to Bain Capital in its acquisition of Surgery Partners from HIG Capital, and also in its acquisition of National Surgical Healthcare from Irving Place Capital. Michael McFalls and Jonathan Klarfeld, who are both based in Washington DC, are recommended individuals in the team. Mark Popofsky, whose practice is split between Washington DC and San Francisco, is overall head of the antitrust group.

In 2017, Shearman & Sterling LLP expanded its footprint in Washington DC by hiring David Higbee, Djordje Petkoski, Ryan Shores and Todd Stenerson from Hunton Andrews Kurth LLP. Bruce Hoffman, who also made the move, subsequently became acting director of the FTC’s Bureau of Competition. Higbee, who is now the global antitrust head, ‘manages his team very efficiently and effectively’. In 2017, New York-based practitioners Jessica Delbaum and associate Aleksandra Petkovic worked with practitioners in the Brussels office to advise B/E Aerospace on the antitrust aspects of its $8.3bn acquisition of Rockwell Collins. In another highlight, Delbaum, New York-based of counsel Wayne Dale Collins and others assisted American Axle & Manufacturing with obtaining clearances in the US, Mexico, South Korea, Austria and Germany of its $3.2bn acquisition of Metaldyne Performance Group. Counsel Daniel Francis, who practises in Washington DC, is also recommended.

Vinson & Elkins LLP’s team, which is chaired by Houston-based James Reeder and Craig Seebald in Washington DC, works closely with the firm’s corporate group to advise on all types of antitrust issues connected with transactions. Its wide-ranging workload includes HSR filings and global merger notifications, merger investigations and litigation. William Vigdor (Washington DC), Reeder, counsel Deborah Milner (Houston) and others represented Plains All American Pipeline (Plains) in an FTC investigation into the client’s agreement with Valero Energy providing for the acquisition by a Valero subsidiary of two petroleum storage facilities in Northern California owned by a subsidiary of Plains. The team also handled a subsequent related lawsuit filed by the Office of the Attorney General for the State of California seeking to block the transaction. Washington DC-based Neil Imus’ work in 2017 included assisting Select Energy Services with antitrust issues associated with its merger with Rockwater Energy Solutions. The team has also acted for clients such as MoneyGram International, Omega Protein and Concho Resources.

WilmerHale’s team, which is led by Thomas Mueller (Washington DC/Brussels), works closely with other offices across the network in industry-defining transactions that attract regulatory scrutiny both inside and outside the US; this was demonstrated in 2017 when Molly Boast (New York) and Hartmut Schneider (Washington DC) worked with the Brussels office to advise Baker Hughes on the global merger review of its $32bn merger with General Electric’s oil and gas unit; the combined entity is now the second-largest oilfield service company in the world. In addition, Boast is working with members of the Berlin office to assist Monsanto with its $66bn sale to Bayer. Leon Greenfield (Washington DC) is another name to note.

Bracewell LLP has an excellent reputation for acting on behalf of energy sector clients, but its merger control work also extends to healthcare, financial services and technology, among other areas. In 2017, New York-based Daniel Hemli and Washington DC-based counsel Jacqueline Java advised Pembina Pipeline on the US antitrust aspects of it’s circa C$9.7bn acquisition of Veresen. The firm’s other energy sector clients include Chevron, Holly Energy Partners and Hydro One. Outside of energy, another highlight involved assisting Delta Card Services, as the holding company of Merchants’ Choice Payment Solutions (MCPS), with the antitrust aspects of MCPS’ sale to Paysafe Group for $470m.

Cahill Gordon & Reindel LLP’s Elai Katz and counsel Lauren Rackow (both in New York) advise clients on transactional antitrust matters arising at all stages of M&A transactions. In 2017, the pair assisted Tembec with obtaining FTC and DOJ clearances for its $807m sale to Rayonier Advanced Materials, and co-ordinated related regulatory approvals in Canada, Germany and China. The team also advised Empire District Electric on obtaining antitrust and CFIUS approvals associated with its acquisition by a subsidiary of Algonquin Power & Utilities.

International comparative guides

Giving the in-house community greater insight to the law and regulations in different jurisdictions.

Select Practice Area

Press releases

The latest news direct from law firms. If you would like to submit press releases for your firm, send an email request to

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to
  • Korean Financial Regulators Advance Legislation to Introduce Regulatory Sandbox to Spark FinTech

    The 2018 year in review in Korea was notable for the sluggish overall economy, uncertainty surrounding the geo-politics and impact on Korea due to the global trade wars, on-going concerns related to the lack of jobs and unemployment, increased taxes and burdens for businesses and families, and no meaningful improvement or clarity in the current situation for 2019. In response, the Korean National Assembly passed a legislation called the Financial Innovation Support Act (the “FinISA”) on December 7, 2018 to spark the financial services industry in conjunction with FinTech products and services. The FinISA, which will soon take effect in March 2019, is intended to lay the legal foundation to introduce a regulatory sandbox for innovative financial services, where FinTech firms test their new products and services without certain regulatory oversight pursuant to exemptions for a limited period of time (“Sandbox”). As the FinISA exempts or defers application of existing finance-related regulations for new financial technology, products or services with the purpose of fostering the creation of innovative and new financial products and services, it will also support the stabilization of such services in the financial services market at the end of the testing period and is expected that the FinISA will support a revitalization of the FinTech industry which experienced sluggish growth in recent times. In particular, as companies and investors become more interested in security tokens and Security Token Offerings (“STO”) which are regulated by the Financial Investment Services and Capital Markets Act (the “FSCMA”), there have been on-going discussions and debates as to whether the FinISA could lead to a breakthrough in the crypto-asset industry based on blockchain technology. Crypto assets encompasses those assets which utilize blockchain technology where the asset is digitalized by utilization of cryptography, peer-to-peer networks and a public ledger of verified transactions resulting in a ‘units’ of such a crypto asset without any involvement by middle-persons or brokers (e.g., cryptocurrency.

    The sacking of Nissan’s high-profile chairman may have beenproof that nobody is infallible. But Nicola Sharp argues that it should also beseen as an indicator that no company can be considered safe from wrongdoing.
  • 2018 FCPA Enforcement Actions and Highlights

    Overall, 2018 was a more active year in terms of Foreign Corrupt Practices Act ("FCPA") enforcement actions compared to 2017.
  • Legality of advertising with statements on the effects of medical treatments

    Advertisements featuring statements on the effects of medical treatments are only permissible if they are supported by sound scientific evidence. This was reaffirmed by the Oberlandesgericht (OLG) Frankfurt, the Higher Regional Court of Frankfurt.
  • Sayenko Kharenko announces new partner promotion

    Sayenko Kharenko announces new partner promotion
  • ECJ – Distinctive character necessary for registration as EU trade mark

    For a sign to be capable of being registered as an EU trade mark, it must be distinctive across the entire European Union. This was confirmed by the Court of Justice of European Union (ECJ) in a ruling from 25 July 2018.
  • Supporting local and international charitable organizations

    As one of the leading law firms in Cyprus, we are active promoters and supporters of local economic growth by sponsoring local events, applying environmental-friendly practices, minimizing our ecological impact, and most importantly, by raising money for local charities and non-profit organizations.
  • BAG – Employers can claw back bonus payments

    The Bundesarbeitsgericht (BAG), Germany’s Federal Labour Court, confirmed in a recent ruling that employers can claw back collectively agreed bonus payments from employees under certain circumstances.
  • Stricter supervision in relation to the Scheme for Naturalisation of Investors in Cyprus by Exceptio

    Recently there were a lot of publications within the European Union expressing concerns about the allegedly very high number of Cypriot passports being given to foreign investors the last few years. The Council of Ministers has decided on 9th January 2018 with the decision with number 84.069, to impose a stricter supervision of all the parties involved in the Scheme for the naturalisation of non-Cypriot investors in Cyprus by exception.
  • 19% VAT on Plots

    In order to harmonize the  Acquis Communautaire on the Taxation of untapped and undeveloped plots of land, the Cyprus Government enacted, on 03/11/2017, relevant legislation for the imposition of 19% Value Added Tax (VAT) on these properties, with a date of enforcement being 02/01/2018. The relevant legislation refers to plots/pieces of land offered and/or provided for construction for economic purposes.

Press Releases worldwide

The latest news direct from law firms. If you would like to submit press releases for your firm, send an email request to